Total Payments
$755.73
2024 Payments
$296.05
Companies
6
Transactions
41
Medicare Patients
693
Medicare Billing
$79,213
Payment Breakdown by Category
Food & Beverage$755.73 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $755.73 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $228.41 | 14 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $194.49 | 9 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $150.92 | 8 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $143.16 | 8 | $0 (2024) |
| Insmed, Inc. | $21.01 | 1 | $0 (2022) |
| MAYNE PHARMA INC. | $17.74 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $296.05 | 16 | Neurocrine Biosciences, Inc. ($88.01) |
| 2023 | $420.93 | 23 | Otsuka America Pharmaceutical, Inc. ($163.57) |
| 2022 | $38.75 | 2 | Insmed, Inc. ($21.01) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Neuropsychiatry | ||||||
| 09/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Central Nervous System | ||||||
| 07/31/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Central Nervous System | ||||||
| 05/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), NUEDEXTA | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Neuropsychiatry | ||||||
| 04/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Central Nervous System | ||||||
| 04/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), NUEDEXTA | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: PSYCHIATRY | ||||||
| 02/22/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: NEUROLOGY | ||||||
| 02/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Neuropsychiatry | ||||||
| 02/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Neuropsychiatry | ||||||
| 01/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Neuropsychiatry | ||||||
| 01/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Central Nervous System | ||||||
| 01/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), NUEDEXTA | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug), REXULTI | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: NEUROLOGY | ||||||
| 11/30/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Neuropsychiatry | ||||||
| 11/29/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Central Nervous System | ||||||
| 11/21/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Neuropsychiatry | ||||||
| 10/24/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/16/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), NUEDEXTA | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: PSYCHIATRY | ||||||
| 09/22/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), NUEDEXTA | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), NUEDEXTA | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), NUEDEXTA | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 582 | 885 | $166,358 | $71,213 |
| 2022 | 3 | 111 | 131 | $15,425 | $7,999 |
Total Patients
693
Total Services
1,016
Medicare Billing
$79,213
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 224 | 381 | $58,651 | $26,958 | 46.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 143 | 226 | $34,790 | $16,012 | 46.0% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 54 | 111 | $24,301 | $9,423 | 38.8% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 42 | 42 | $17,153 | $7,522 | 43.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 61 | 61 | $20,826 | $6,988 | 33.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 14 | 14 | $4,780 | $1,832 | 38.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 23 | 27 | $3,163 | $1,339 | 42.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 21 | 23 | $2,694 | $1,139 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 75 | $8,175 | $4,355 | 53.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 38 | $6,080 | $3,191 | 52.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 18 | $1,170 | $453.56 | 38.8% |
About Kaydean Vickers, FNP
Kaydean Vickers, FNP is a Family healthcare provider based in Arcadia, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2018. The National Provider Identifier (NPI) number assigned to this provider is 1063908242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kaydean Vickers, FNP has received a total of $755.73 in payments from pharmaceutical and medical device companies, with $296.05 received in 2024. These payments were reported across 41 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($755.73).
As a Medicare-enrolled provider, Vickers has provided services to 693 Medicare beneficiaries, totaling 1,016 services with total Medicare billing of $79,213. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Psychiatric/Mental Health
- Location Arcadia, FL
- Active Since 07/10/2018
- Last Updated 08/02/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1063908242
Products in Payments
- NUPLAZID (Drug) $194.49
- INGREZZA (Drug) $150.92
- REXULTI (Drug) $136.72
- Austedo XR (Drug) $105.04
- NUEDEXTA (Drug) $91.69
- AUSTEDO (Drug) $38.12
- Arikayce (Drug) $21.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Arcadia
Ms. Lynsey Lakin, Fnp-C, FNP-C
Family — Payments: $329,984
Family $329,984
Liang Zhu
Family — Payments: $6,987
Family $6,987
Sheila Che
Family — Payments: $3,005
Family $3,005
Su Sung
Family — Payments: $2,184
Family $2,184
Yanet Quiles, Aprn,Pmhnp, APRN,PMHNP
Family — Payments: $1,411
Family $1,411
Yixuan Chang
Family — Payments: $1,363
Family $1,363